Synteract Thought Leaders to Speak & Exhibit at Partnerships in Clinical Trials Europe in Amsterdam
(Booth #17) – Thought leaders from Synteract , a full-service, international contract research organization (CRO), will exhibit and present at Partnerships in Clinical Trials Europe (PCT), November 28-29, Amsterdam, Netherlands. With awareness of the shifting CRO landscape and the complexity this represents to biopharma companies as they make critical outsourcing decisions, Synteract invites attendees to “Pause to rethink what matters most from your CRO.”
Vice President, Global Medical and Regulatory Affairs at Synteract, Dr. Martine Dehlinger-Kremer , will speak on “The EU Clinical Trials Regulation: Are you prepared for its implementation?” at the event on Tuesday, November 28 at noon. She will address how evolving industry needs are driving momentum towards implementation of a new regulation governing clinical trials, the expected impact on sponsors and necessary steps toward preparedness.
Attendees are encouraged to stop by Booth #17 for coffee and conversation. They can also contact Trisha Vonder Reith, executive director marketing communications at firstname.lastname@example.org to set up a specific appointment time.
With 800 staff members across 21 countries, SynteractHCR is an international full-service contract research organization with a successful three-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in more than 60 countries, offering broad therapeutic expertise, with notable depth in oncology, immunotherapy, CNS and infectious disease, among other indications. With its “Shared Work – Shared Vision ” philosophy, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data to help bring tomorrow’s treatments to patients.
Hilary McCarthy, 508-829-2543
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
CA-RESMED21.1.2019 15:07 | Pressemeddelelse
ResMed’s First Top-of-Head CPAP Mask, AirFit N30i, Now Available across U.S.
NC-METABOLON21.1.2019 14:08 | Pressemeddelelse
Metabolon Appoints Michael Rasche as President of International Business
AMCS21.1.2019 14:02 | Pressemeddelelse
AMCS Announces Acquisition of Recy Systems
VERTEX21.1.2019 10:02 | Pressemeddelelse
Vertex Announces European Commission Approval for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease
B2C221.1.2019 10:02 | Pressemeddelelse
B2C2 Launches Streaming OTC Pricing with Point-and-Click Execution
GSMA21.1.2019 10:02 | Pressemeddelelse
Anticipation Builds as MWC19 Barcelona Approaches
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum